Detalhe da pesquisa
1.
Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia.
Haematologica
; 108(1): 61-68, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924580
2.
Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study.
Ann Hematol
; 100(11): 2787-2797, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476574
3.
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(7): 1407-1415, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871978
4.
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.
Haematologica
; 104(1): 113-119, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076173
5.
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
Biol Blood Marrow Transplant
; 24(7): 1471-1475, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29477779
6.
Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors.
Biol Blood Marrow Transplant
; 24(5): 1013-1021, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29337223
7.
Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.
Cancer
; 123(15): 2867-2874, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28387928
8.
Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia.
Br J Haematol
; 198(4): 780-784, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615877
9.
Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia.
Haematologica
; 102(7): 1227-1237, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28302711
10.
Trichosporon: another yeast-like organism responsible for immune reconstitution inflammatory syndrome in patients with hematological malignancy.
Hematol Oncol
; 35(4): 900-904, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27301878
11.
A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study.
Am J Hematol
; 90(9): 811-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26094614
12.
Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact.
Clin Hematol Int
; 6(1): 26-38, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817703
13.
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Lancet
; 379(9825): 1508-16, 2012 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22482940
14.
The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.
Blood
; 127(17): 2157-60, 2016 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26929274
15.
Administration of alemtuzumab and G-CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase II study.
Eur J Haematol
; 91(4): 315-21, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23738686
16.
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation.
Bone Marrow Transplant
; 58(1): 61-67, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36224494
17.
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation.
Bone Marrow Transplant
; 58(11): 1215-1222, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596473
18.
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial.
Blood Adv
; 7(21): 6441-6450, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37581981
19.
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.
Blood Adv
; 7(13): 3117-3127, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724515
20.
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia.
Invest New Drugs
; 30(3): 1121-31, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21519855